Literature DB >> 10581846

Phenotype of mast cells in the brain tumor. Capillary hemangioblastoma.

D Maślińska1, R Woźniak, A Kaliszek, B Schmidt-Sidor, A Lipska, D E Woolley.   

Abstract

Mast cells (MC) are heterogenous cell population. In normal human brain they are not numerous. Increases in number of mast cells within CNS occur in certain disease states including neoplasms. In capillary hemangioblastoma several authors reported mast cells as a fourth cell type of the tumor. The aim of the present study was to examine phenotype and distribution of MC in cerebellar capillary hemangioblastoma by means of specific immunological markers. Study was performed on the tumor of ten affected individuals. Tumor specimens of seven cases were fixed in formalin and embedded in paraffin wax. Additional three tumours were fresh-frozen samples. Mast cells were identified with two monoclonal antibodies generated against tryptase and chymase. In all capillary hemangioblastomas mast cells were numerous exclusively in the tumor mass and only occasionally found in adjacent or far from the tumor located areas of the cerebellum. The cells contained tryptase and chymase. At periphery of hemangioblastomas some mast cells underwent degeneration and calcification. Our results confirm previous observations that mast cells are numerous in the capillary hemangioblastoma and show that most of these cells are tryptase/chymase phenotype (MCTC).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581846

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  2 in total

1.  Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.

Authors:  S Epari; M C Sharma; C Sarkar; A Garg; A Gupta; V S Mehta
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

Review 2.  Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.